Search Within

Yasser Mohamed Ali Ged

Formats
  1. Meeting Abstract (10)
  2. Journal Article (9)
Groups
  1. Department of Medicine (18)
  2. Genitourinary Oncology Service (18)
  3. Solid Tumor Oncology Division (18)
  4. Biostatistics Service (16)
  5. Epidemiology and Biostatistics (16)
  6. Weinberg Fellows (15)

More Groups

People
  1. Martin Voss (18)
  2. Robert Motzer (17)
  3. Chung-Han Lee (15)
  4. Sujata Patil (14)
  5. Darren Feldman (13)
  6. Maria Carlo (12)

More People

Years
  1. 2022 (1)
  2. 2020 (6)
  3. 2019 (7)
  4. 2018 (5)
Publications
  1. Journal of Clinical Oncology (10)
  2. Clinical Genitourinary Cancer (2)
  3. BMC Urology (1)
  4. Cancer (1)
  5. Clinical Cancer Research (1)
  6. JCO Precision Oncology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (11)
  2. Biomed Central Ltd (2)
  3. Elsevier Inc. (2)
  4. American Association for Cancer Research (1)
  5. Elsevier Science, Inc. (1)
  6. Nature Publishing Group (1)

More Publishers

Results (19)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Alterations in DNA damage repair (DDR) genes and outcomes to systemic therapy in 225 immune-oncology (10) versus tyrosine kinase inhibitor (TKI) treated metastatic clear cell renal cell carcinoma (mccRCC) patients (pts)
    Meeting Abstract

    Ged, Y.; Chaim, J.; Knezevic, A.; Carlo, M. I.; Foster, A.; Feldman, D. R.; Teo, M. Y.; Riaz, N.; Lee, C. H.; Patil, S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • The impact of PBRM1 mutations on overall survival in greater than 2,100 patients treated with immune checkpoint blockade (ICB)
    Meeting Abstract

    Hakimi, A. A.; Ged, Y.; Flynn, J.; Hoen, D. R.; Di Natale, R. G.; Blum, K. A.; Makarov, V.; Kuo, F.; Carlo, M. I.; Lee, C. H.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Mucinous tubular and spindle-cell carcinoma of the kidney: Clinical features, genomic profiles, and treatment outcomes
    Journal Article

    Ged, Y.; Chen, Y. B.; Knezevic, A.; Donoghue, M. T. A.; Carlo, M. I.; Lee, C. H.; Feldman, D. R.; Patil, S.; Hakimi, A. A.; Russo, P.; more...
    Clinical Genitourinary Cancer (2019)

    Fulltext@MSK | Save
  • Metastatic chromophobe renal cell carcinoma: Presence or absence of sarcomatoid differentiation determines clinical course and treatment outcomes
    Journal Article

    Ged, Y.; Chen, Y. B.; Knezevic, A.; Casuscelli, J.; Redzematovic, A.; DiNatale, R. G.; Carlo, M. I.; Lee, C. H.; Feldman, D. R.; Patil, S.; more...
    Clinical Genitourinary Cancer (2019)

    Fulltext@MSK | Save
  • Single-center analysis of 109 patients (pts) with metastatic chromophobe renal cell carcinoma (ChRCC): Differences in outcomes by histologic variant
    Meeting Abstract

    Ged, Y.; Knezevic, A.; Chen, Y.; Redzematovic, A.; Carlo, M. I.; Lee, C. H.; Feldman, D. R.; Patil, S.; Motzer, R. J.; Voss, M. H.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Alterations in key clear cell renal cell carcinoma (RCC) genes to refine patient prognosis
    Meeting Abstract

    BosseĢ, D.; Xie, W.; Ged, Y.; Hahn, A. W.; Bergerot, P. G.; Ho, T. H.; McKay, R. R.; Rose, T. L.; de Velasco, G.; Tannir, N. M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Everolimus (E) plus bevacizumab (B) is effective first-line treatment for patients (pts) with advanced renal cell carcinoma (RCC) with papillary features (PF): Results from a phase II trial
    Meeting Abstract

    Feldman, D. R.; Lee, C. H.; Molina, A. M.; Knezevic, A.; Chen, Y.; Chaim, J.; Coskey, D. T.; Ged, Y.; Tickoo, S.; Reuter, V. E.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Outcomes of metastatic chromophobe renal cell carcinoma (ChRCC) with sarcomatoid features (SF)
    Meeting Abstract

    Ged, Y.; Knezevic, A.; Chen, Y.; Redzematovic, A.; Carlo, M. I.; Lee, C. H.; Feldman, D. R.; Patil, S.; Motzer, R. J.; Voss, M. H.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Prostate-specific membrane antigen (PSMA) PET-CT imaging in the investigation and management of biochemical recurrence in prostate cancer
    Meeting Abstract

    Keane, F.; Ged, Y.; Greally, M.; Maher, M. A.; O'Malley, K.; McCaffrey, J.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save